ArticleBrain : a journal of neurology2020

Corrigendum to: Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.